Gateway to Growth: Innovation and Opportunity at the 8th China International Import Expo (CIIE)
PorAinvest
lunes, 1 de septiembre de 2025, 12:10 pm ET1 min de lectura
BSX--
Novartis, a prominent pharmaceutical company, is one of the key players at the 8th CIIE. At the 4th CIIE, Novartis debuted Radioligand Therapy (RLT), a cutting-edge medical innovation. Leveraging the spillover effect of the CIIE, Novartis signed strategic partnerships with three Chinese partners—GE Healthcare China, Shanghai Pharmaceutical Holding, and Chongqing Pharmaceutical Holding—at the 7th CIIE. These collaborations have facilitated the speedy launch and expansion of RLT in China [1].
Boston Scientific is another company that has seen its products move from the expo floor to the market. Several of its products, which were showcased at the 7th CIIE, have successfully entered the Chinese market. Johnson & Johnson, expanding its booth to 700 square meters this year, will feature the MONARCH surgical robot and the lung cancer therapy Rukobia® at the 8th CIIE [1].
In parallel with the 8th CIIE, the Hongqiao International Economic Forum (HQF) is set to take place. The 8th HQF, with the theme "Opening Up for New Opportunities, Collaborating for a Shared Future," will feature more than 20 sessions on topics such as cooperation, innovation, development, and sharing. This year's forum will see active participation from international bodies like UNICEF and UNIDO, alongside government officials and industry leaders. The release of the World Openness Report 2025 will be a key highlight of the 8th HQF, emphasizing its role as a platform for global dialogue and collaboration [1].
The 8th CIIE offers unparalleled opportunities for businesses to connect, innovate, and grow. For those interested in participating, the latest updates and details can be found at [https://www.ciie.org/zbh/en/](https://www.ciie.org/zbh/en/) [1].
References:
[1] https://www.businesswire.com/news/home/20250901129755/en/Gateway-to-Growth-Innovation-and-Opportunity-at-the-8th-CIIE
NVS--
The China International Import Expo (CIIE) is set to showcase innovation, foster cooperation, and expand access to the Chinese market for global enterprises. The 8th CIIE will feature exhibits that have successfully entered the market after their debut at previous expos, including medical innovations from companies like Novartis and Boston Scientific. The Hongqiao International Economic Forum will also take place, focusing on themes like opening up for cooperation, innovation, development, and sharing.
The China International Import Expo (CIIE) is set to showcase innovation, foster cooperation, and expand access to the Chinese market for global enterprises. The 8th CIIE, scheduled to take place in Shanghai, promises to be a pivotal event in the global economic landscape. This year's expo will feature exhibits that have successfully transitioned from debuts at previous expos into marketable goods, underscoring the CIIE's role in driving market growth and innovation.Novartis, a prominent pharmaceutical company, is one of the key players at the 8th CIIE. At the 4th CIIE, Novartis debuted Radioligand Therapy (RLT), a cutting-edge medical innovation. Leveraging the spillover effect of the CIIE, Novartis signed strategic partnerships with three Chinese partners—GE Healthcare China, Shanghai Pharmaceutical Holding, and Chongqing Pharmaceutical Holding—at the 7th CIIE. These collaborations have facilitated the speedy launch and expansion of RLT in China [1].
Boston Scientific is another company that has seen its products move from the expo floor to the market. Several of its products, which were showcased at the 7th CIIE, have successfully entered the Chinese market. Johnson & Johnson, expanding its booth to 700 square meters this year, will feature the MONARCH surgical robot and the lung cancer therapy Rukobia® at the 8th CIIE [1].
In parallel with the 8th CIIE, the Hongqiao International Economic Forum (HQF) is set to take place. The 8th HQF, with the theme "Opening Up for New Opportunities, Collaborating for a Shared Future," will feature more than 20 sessions on topics such as cooperation, innovation, development, and sharing. This year's forum will see active participation from international bodies like UNICEF and UNIDO, alongside government officials and industry leaders. The release of the World Openness Report 2025 will be a key highlight of the 8th HQF, emphasizing its role as a platform for global dialogue and collaboration [1].
The 8th CIIE offers unparalleled opportunities for businesses to connect, innovate, and grow. For those interested in participating, the latest updates and details can be found at [https://www.ciie.org/zbh/en/](https://www.ciie.org/zbh/en/) [1].
References:
[1] https://www.businesswire.com/news/home/20250901129755/en/Gateway-to-Growth-Innovation-and-Opportunity-at-the-8th-CIIE
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios